|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.02.26 - 13:06
|
Broadridge Reports Second Quarter Fiscal 2026 Results (PR Newswire)
|
|
|
Recurring revenues grew 9%; up 8% constant currency Diluted EPS was $2.42 and Adjusted EPS rose 2% to $1.59 Raising outlook for FY'26 Adjusted EPS growth to 9-12% Reaffirming FY'26 guidance including Recurring revenue growth constant currency, Adjusted Operating income margin, and Closed......
|
|
|
|
|
|
|
|
|
|
|
27.01.26 - 15:06
|
Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer (Business Wire)
|
|
|
AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced the preliminary results of its voluntary self-tender offer to purchase 300,000 shares of its common stock, par value $0.001 per share (“Common Stock”), which expired one minute after 11:59 p.m., New York City time, on January 26, 2026.
Based on the preliminary count by Broadridge Corporate Issuer Solutions, LLC, the depositary for the tender offer, a total of 4,897,188 shares of Common Stock were properly tendered and not properly withdrawn, excluding 10,868 shares that were tendered by notice of guaranteed delivery.
The tender offer was oversubscribed. In accordance with the terms and conditions of the tender offer and based on the preliminary count by the depositary, Anebulo expects to accept for payment an aggregate of 300,000 shares of its ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|